SCHEMBL6654437

SCHEMBL6654437

CN(C)CCCOC(Cl)c1ccccc1Cc1nccn1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.38
HRH4 Q9H3N8 1/20 0.35
LMNA P02545 1/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2D6 P10635 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
KDM4E B2RXH2 2/20 0.33
LSS P48449 1/20 0.33
GUCY1B2 O75343 1/20 0.33
CHRM2 P08172 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CHRM1 P11229 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
GUCY1A2 P33402 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6650132 0.83 HRH3 (0.33) CYP1A2CYP2D6HRH3KDM4EGUCY1B2
SCHEMBL6654163 0.82 HRH3 (0.35) HRH1LMNACYP1A2CYP2D6HRH3
SCHEMBL6651103 0.80 OPRK1 (0.36) HRH1HRH4LMNACYP1A2CYP2D6
SCHEMBL6648694 0.78 TRPM5 (0.38) HRH1CYP1A2CYP2D6HRH3KDM4E
SCHEMBL6648700 0.76 HRH3 (0.35) HRH1CYP1A2CYP2D6HRH3KDM4E
SCHEMBL6650011 0.76 DRD4 (0.40) HRH1HRH4LMNACYP1A2CYP2D6
SCHEMBL6672328 0.76 TRPM5 (0.32) HRH1LMNACYP2D6HRH3CHRM2
SCHEMBL6650451 0.74 LMNA (0.39) HRH1HRH4LMNACYP1A2CYP2D6
SCHEMBL6654434 0.74 DRD4 (0.37) HRH1HRH4LMNACYP1A2CYP2D6
SCHEMBL6651257 0.74 KMT2A (0.44) LMNACYP2D6KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1103243-B1 UTILIZATION OF ARYL(OR HETEROARYL)AZOLYLCARBINOL DERIVATIVES FOR THE TREATMENT OF TROUBLES MEDIATED BY AN EXCESS OF SUBSTANCE P ESTEVE LABOR DR (ES) 2004-01-07 EP claimed